Replies to post #712034 on NorthWest Biotherapeutics Inc (NWBO)

[meirluc]

[quotSo, I'm ready to hear that the first unit will arrive in X-number of weeks or months. Or better, that it has arrived and is hooked up and ready to go through validation runse][/quote]

If it still takes a number of months for the first Eden unit(s) to be validated, do
you believe that the MHRA would delay the MAA approval until at least that
first unit(s) is validated? That may take months after completion of
the inspections that LP had mentioned which may already be taking place
right now. I certainly hope that we do not have to wait for approval until
December.

[Doc logic]

beartrap12,

I personally believe that the announcement in the Q is enough for approval with artisan but not NWBO and NICE know where this is very likely headed beyond GBM and rGBM so they want to see as much advancement as possible. Having a GMP unit in hand that functions as well or better than non GMP prototypes in my opinion is enough for a green light on approval. The rest should be finished up in the next 16 months. Best wishes.

[Lykiri]

I say this because the UK, according to statistics, has about 1,500 new GBM patients a year.

The UK has 4500 newly diagnosed GBM patients a year.

June 26th.- Presentation Professor Ashkan Keyoumars (picture 2)

👏 🧬💉🧠Incredible talk! Massive thank you to Professor Ashkan for the talk on Glioblastoma research!

Thank you to everyone who joined us! We hope you enjoyed the talk as much as we did!

See you all in September! ☀️ pic.twitter.com/GiMzZyBhOZ

— Brain School (@BrainSchool101) June 28, 2024

[maverick_1]

Beartrap’s

I say this because the UK, according to statistics, has about 1,500 new GBM patients a year The artisan method will only handle about 500 per year
So without Eden units up and running, we immediately start out overwhelmed in the manufacturing of our product.

ACTUALLY 3 yearS ago DEFIES the above: 3200 YR

Glioblastoma is a very aggressive brain tumour with around 2,200 cases diagnosed each year in England (AND around 3,200 across the UK).

https://www.ucl.ac.uk/news/2021/jul/brain-cancer-trial-recruits-largest-ever-number-patients
That was in UCL lead investigator Dr Paul Mulholland’s GBM trial

The juxtaposition of EDEN units to ACTUAL size of UK market is a widening fault.

Also
DAY of INFAMY for DARK FORCES & WallSt collusion in NUKED NWBO shares
https://nwbio.com/presentation-about-phase-3-trial-of-dcvax-l-for-glioblastoma/

May 10, 2022 77 mln shs traded: Hi ~$2.00 Low ~38 cents
re Yahoo Finance HIstorical price data

That despite pleas by The MAESTRO for a HALT in trading
the collusionary DARK Forces & WallSt prevailed
Over the substitute for Dr. Linda Liau NYAS Presentation was Dr Paul McHolland

DIFFERENT STROKES for DIFFERENT FOLKS

The BANTER is getting there.